IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
559.51
+2.58 (0.46%)
At close: Aug 24, 2026, 4:00 PM EDT
558.60
-0.91 (-0.16%)
After-hours: Aug 24, 2026, 7:45 PM EDT

IDEXX Laboratories Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,1401,059887.87845.04679.09744.85
Depreciation & Amortization
154.08145.18129.94114.91111.9104.6
Asset Writedown & Restructuring Costs
----2.355.15
Loss (Gain) From Sale of Investments
5-----
Stock-Based Compensation
62.9760.0160.359.7449.7737.76
Provision & Write-off of Bad Debts
10.348.436.875.555.831.48
Other Operating Activities
149.12136.23-22.73-46.3-32.42-0.76
Change in Accounts Receivable
-76.68-68.72-28.28-53.87-41.4-33.14
Change in Inventory
1.51-0.79-28-28.65-121.73-52.92
Change in Accounts Payable
8.02-8.578.09-0.563.4711.23
Change in Unearned Revenue
6.936.93-4.38-3.03-11.02-7.55
Change in Other Net Operating Assets
-89.44-156.36-80.6713.68-102.85-55.15
Operating Cash Flow
1,3721,182929906.51542.98755.55
Operating Cash Flow Growth
51.41%27.21%2.48%66.95%-28.13%16.59%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-117.18-124.68-120.92-133.63-148.84-119.55
Cash Acquisitions
---76.69--11.51-173.42
Sale (Purchase) of Intangibles
-17.24-13.55-10--10-
Investment in Securities
-1.56-0.76-1--25-
Other Investing Activities
3.932.741.568.38--
Investing Cash Flow
-132.04-136.24-207.06-125.25-195.35-292.97

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-148--505.573.5
Long-Term Debt Issued
-250----
Total Debt Issued
190398--505.573.5
Short-Term Debt Repaid
----329--
Long-Term Debt Repaid
--428.39-75-75-75-50
Total Debt Repaid
-325-428.39-75-404-75-50
Net Debt Issued (Repaid)
-135-30.39-75-404430.523.5
Issuance of Common Stock
119.9193.3644.4947.0335.7546.57
Repurchase of Common Stock
-1,187-1,224-847.57-81.9-830.32-762.34
Other Financing Activities
-3.74-3.74--3.14-6.87-5.14
Financing Cash Flow
-1,206-1,165-878.07-442-370.94-697.41

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1.511.2-9.532.13-8.61-4.64
Net Cash Flow
32.34-108.2-165.67341.39-31.91-239.47

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,2541,057808.08772.88394.15636
Free Cash Flow Growth
59.92%30.82%4.55%96.09%-38.03%17.54%
Free Cash Flow Margin
27.55%24.56%20.73%21.11%11.71%19.78%
Free Cash Flow Per Share
15.6513.059.719.204.667.35
Levered Free Cash Flow
909.37790.74734.99693.69328.16534.41
Unlevered Free Cash Flow
932.99815.02754.49719.68353.07553.04

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
37.737.733.84140.330.5
Cash Income Tax Paid
137.2167.5307.2192.5239.8161.7
Change in Working Capital
-149.66-227.51-133.24-72.43-273.53-137.52
SEC Filings: 10-K · 10-Q